<li id="omoqo"></li>
  • <noscript id="omoqo"><kbd id="omoqo"></kbd></noscript>
  • <td id="omoqo"></td>
  • <option id="omoqo"><noscript id="omoqo"></noscript></option>
  • <noscript id="omoqo"><source id="omoqo"></source></noscript>
  • 發布時間:2019-04-26 14:51 原文鏈接: Isolation,Culture,andDifferentiationofProgenitorCells2

    Slide Coating


    • 13. Just before use, dilute the poly-D-lysine stock solution 1:50 in H2O. Add 0.2 mL of diluted poly-D-lysine to each well of an eight-well chamber slide. Incubate for 1 h at room temperature.

    • 14. Wash wells three times with H2O. Add 0.2 mL of diluted laminin to each well and incubate overnight at 4°C. 
      Store slides at 4°C until use and wrap in parafilm to minimize evaporation. 

    • 15. Before use, remove laminin and wash wells once with Neurobasal medium (PSG). 
      Do not remove the laminin from the wells until immediately before use. 

    Differentiation


    • 16. Add 100 μL of NEP complete medium to each well of a poly-D-lysine/laminin-coated eight-well chamber slide (prepared as described in Steps 13-15). Transfer one sphere (from Step 12) to each well using a P200 pipette and incubate overnight at 37°C. 

    • 17. After 24 h, ensure spheres have attached to the slide (Fig. 3B); then carefully remove medium. Add 200 μL of NEP basal medium containing 2% heat-inactivated horse serum. 

    • 18. Culture for 2-3 d, changing medium daily. 

    • 19. For fixation and subsequent immunohistochemical analysis (Fig. 3C), remove medium, rinse once with 1X PBS, and fix with 4% PFA in 1X PBS for 1 h at 4°C. 

    Secondary Neurospheres


    • 20. Using a P20 or P200 pipette, mechanically dissociate a single neurosphere in a 1.5-mL microcentrifuge tube. 
      If this is difficult, incubate spheres in trypsin for 5 min and dissociate mechanically. 

    • 21. Centrifuge the cells at 3000 rpm for 5 min and resuspend in NEP complete medium. 
      Plate cells individually in 96-well, low cell binding plates or bulk passage multiple spheres asdescribed in Step 10. 


    DISCUSSION

    The development of a cell culture system designed to isolate and propagate putative stem cells from neural tissue (Reynolds and Weiss 1992; Reynolds et al. 1992) has greatly advanced ourunderstanding of these cell populations. This technique has not only provided a means to monitor the physical characteristics of these cells, but has also enhanced our ability to manipulate the genetic and epigenetic factors that regulate both their capacity to self-renew and to differentiate into the three defined cell types of the nervous system: neurons, astrocytes, and oligodendrocytes. In the presence of epidermal growth factor (EGF) and/or basic fibroblast growth factor (bFGF), these cell populations can be reliably expanded and maintained in the form of neurospheres and, upon removal of these growth factors, can efficiently generate the three major CNS cell types.

    Advances in mouse genetic manipulation, as well as the development of more powerful analytical technologies (e.g., FACS), have resulted in the development of multiple modified protocols of the neurosphere assay. For instance, the utilization of mouse lines containing multiple targeted mutations typically generates only a small fraction of animals carrying the desired genotype. Given that the total percentage of neural stem cells can be quite small (<0.1% in adults [Reynolds and Weiss 1992]), it is often important to maximize the yield of neural stem cells from these animals. We have found that the often-used trypsin-basedenzymatic dissociation can be deleterious to cells, resulting in a high percentage of cell death after isolation. Here we provide an alternative protocol utilizing the enzyme papain, which, in our hands, is more efficient and less destructive in dissociating neural tissue, and therefore provides a greater yield of viable stem cells. It should be noted, however, that we have found that culture conditions, including enzymatic incubation times and plating densities, vary between age points as well as different neural stem cell populations, and therefore may need to be determined on an individual basis.

    Although historically utilized as a means to retrospectively identify neural progenitors, today the NSA can be used in the prospective isolation and propagation of neural progenitors. The generation of mouse strains expressing fluorescent proteins under the control of neural progenitor specific markers (Nestin-EGFP [Kawaguchi et al. 2001], Sox2-EGFP [Ellis et al. 2004], and hGFAP-EGFP [Zhuo et al. 1997]), coupled with the ability to efficiently isolate these cell types using FACS, has allowed the culture of highly enriched populations of neural progenitor cells, and, using the NSA, examination of the proliferative, self-renewal, and multipotential capacities of these cells in vitro.


    REFERENCES


    1. Ellis P., Fagan B.M., Magness S.T., Hutton S., Taranova O., Hayashi S., McMahon A., Rao M., Pevny L. 2004. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev. Neurosci 26: 148–165.[Medline]

    2. Kawaguchi A., Miyata T., Sawamoto K., Takashita N., Murayama A., Akamatsu W., Ogawa M., Tano Y., Goldman S.A., Okano H. 2001. Nestin-EGFP transgenic mice: Visualization of the self-renewal and multipotency of CNS stem cells. Mol. Cell Neurosci 17: 259–273.[Medline]

    3. Polleux F., Ghosh A. 2002. The slice overlay assay: A versatile tool to study the influence of extracellular signals on neuronal development. Sci. STKE 136: PL9. doi: 10.1126/stke.2002.136.pl9.

    4. Reynolds B.A., Weiss S. 1992. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707–1710.[Abstract/Free Full Text]

    5. Reynolds B.A., Tetzlaff W., Weiss S. 1992. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci 12: 4565–4574.[Abstract]

    6. Zhuo L., Sun B., Zhang C.L., Fine A., Chiu S.Y., Messing A. 1997. Live astrocytes visualized by green fluorescent protein in transgenic mice. Dev. Biol 187: 36–42.[Medline]


    相關文章

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    發力癌癥分子病理診斷,無錫臻和全資收購TissueofOrigin?

    2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和專利轉讓協議,全資收購這款唯一獲FDA......

    這3個雜志撤回中國學者249篇文章,包含上交、中山等名校

    2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......

    研究發現肝臟腫瘤逃脫自然殺傷細胞免疫監視新機制

    自然殺傷細胞(Naturalkillercells,NKcells)是一種效應性淋巴細胞,在人體抗腫瘤過程中發揮重要作用,但是,仍然有一些腫瘤細胞能夠逃避機體NK細胞的攻擊,逐步發生發展,侵襲轉移,嚴......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    StemCellsDev:發現骨形成的新型調節因子

    研究人員發現了小鼠體內一種新的轉錄因子可以幫助調節間充質干細胞(mesenchymalstemcells,MSCs)分化為骨的過程。目前科學家們對于骨細胞分化的研究并不深入,而MSCs則是再生醫學領域......

    llumina宣布推出新型基因分型芯片|支持AllofUs研究計劃

    2018年12月6日,來自圣迭戈的消息——Illumina公司(納斯達克股票代碼:ILMN)今天宣布推出新型高密度基因分型芯片Infinium?GlobalDiversityArray。這款芯片設計源......

    SDSPAGE異常電泳現象及分析SDSPAGEHallofShame

    SDS-PAGE異常電泳現象及分析SDS-PAGEHallofShame.pdf  很不錯的東東~~推薦下~......

    Preparationofdenaturing6%

    Preparationofdenaturing6%polyacrylamidegelsformicrosatelliteanalysis(alsoforSSAP,high-resolutionIRAP......

    <li id="omoqo"></li>
  • <noscript id="omoqo"><kbd id="omoqo"></kbd></noscript>
  • <td id="omoqo"></td>
  • <option id="omoqo"><noscript id="omoqo"></noscript></option>
  • <noscript id="omoqo"><source id="omoqo"></source></noscript>
  • 1v3多肉多车高校生活的玩视频